FDA Approved Medical Products for:
The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.
(Bristol-Myers Squibb Pharmaceutical Research Institute)
The FDA has approved this product to be used in this manner.
|Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information